Search results
Results from the WOW.Com Content Network
Pyrazinamide is used in the first 2 months of treatment to reduce the duration of treatment required. [7] Regimens not containing pyrazinamide must be taken for 9 months or more. Pyrazinamide is a potent antiuricosuric drug [8] and consequently has an off-label use in the diagnosis of causes of hypouricemia and hyperuricosuria. [9] It acts on ...
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB.. The medical standard for active TB is a short course treatment involving a combination of isoniazid, rifampicin (also known as Rifampin), pyrazinamide, and ethambutol for the first two months.
It is a fixed dose combination of rifampicin, isoniazid, and pyrazinamide. [1] It is used either by itself or along with other antituberculosis medication . [ 1 ] It is taken by mouth .
2RZ — The two-month regimen of rifampin and pyrazinamide is no longer recommended for treatment of LTBI because of the greatly increased risk of drug-induced hepatitis and death. [32] 3HP – three-month (12-dose) regimen of weekly rifapentine and isoniazid. [33] [34] The 3HP regimen has to be administered under DOT. A self-administered ...
Multidrug-resistant tuberculosis (MDR-TB) is a form of tuberculosis (TB) infection caused by bacteria that are resistant to treatment with at least two of the most powerful first-line anti-TB medications (drugs): isoniazid and rifampicin.
Pyrazinoic acid is a pyrazinamide metabolite. Possible role in tuberculosis treatment. Pyrazinamid is currently used as a treatment for tuberculosis.
The recommended treatment of new-onset pulmonary tuberculosis, as of 2010, is six months of a combination of antibiotics containing rifampicin, isoniazid, pyrazinamide, and ethambutol for the first two months, and only rifampicin and isoniazid for the last four months. [14]
[17] [22] The regimen usually consists of an initial 2-month intensive phase of Isoniazid (INH), Rifampin (RIF), Pyrazinamide (PZA), and Ethambutol (EMB). [17] Following the 2-month initial phase, PZA and EMB are discontinued while INH and RIF are continued for the remaining four to seven month continuation phase of the treatment period. [17]